Aptahome
Aptahem receives SEK 4,8 million through rights issue
Bioteknik
News roundup Tuesday, June 3
News roundup Wednesday, May 28
News roundup Tuesday, May 27
News roundup Monday, May 26
News roundup Thursday, May 22
News roundup Wednesday, May 21
Aptahem reports partner interest from European pharmaceutical company
Biotechnology company Aptahem, which develops RNA-based therapies for severe...
News roundup Friday, May 16
Aptahem publishes issuance documents
Aptahem has published an information document for its rights issue....
Aptahem plans for a rights issue of SEK 9.7 million
Swedish biotech company Aptahem has announced a rights...
News roundup Wednesday, May 7
Curasight
Notes
Cantargia publishes data for nadunolimab in lung cancer
Genmab reports sales of DARZALEX
AlzeCure receives additional subscription commitments of SEK 7 million
AstraZeneca updates on phase III study
Orexo maintains full-year forecast despite currency headwinds
NEWSLETTER
NEWS
Biovica's blood test provides new answers for cancer care
Green light for PHI to step up its commercial strategy
Enzymatica's CEO comments on his resignation
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
